Skip to main content
Caplight Logo









Nanoplasmas

Nanoplasmas

Private
GreeceHealthcare & Life Scienceshttps://nanoplasmas.com/

Last Round

Grant

Sep 29, 2020

Total Funding Raised

$170,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nanoplasmas is a biotechnology company that develops and manufactures high-end diagnostic consumables and lab-on-chip devices for health, food safety, and environmental applications using patented plasma nanotechnology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Environmental Monitoring, Sensors, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

lab-on-a-chipmolecular diagnosticspathogen detectionpoint-of-need testingmicrofluidicssurface engineeringplasma nanotexturingin vitro diagnosticsIVDrapid testingenvironmental monitoringfood safety testingwater quality testingportable diagnostic devicebiosensorslab-in-a-boxnanotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanoplasmas Comparables

Compare Nanoplasmas with similar companies based on industry and business-model similarity.

Nanoplasmas comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
rqmicro AG
81%
LuminUltra
78%
Diamidex
76%

Nanoplasmas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 29, 2020
GrantJun 16, 2020
SeedFeb 1, 2019

Key People

Founding team and executive leadership

George Papavieros

Chief Operating Officer

Executive Team

Nanoplasmas Investors

Notable investors and investment history

Nanoplasmas investors
InvestorRounds
Uni.FundSeed
European Regional Development FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 64% MoM, reaching 1.4K.

  • Sep 29, 2020

    Received funding from the European Regional Development Fund.

Nanoplasmas Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanoplasmas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanoplasmas's valuation, stock price, and market status.

Firmographic Details

HeadquartersGreece
Employee Range5
Year Founded2016
Last FundingSep 29, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?